Skip to content

NewsnReleases

  • Home
  • Euronext
  • Australian Exchange
  • London Stock Exchange
  • Wire
  • Business & Finance
  • Contact Us
NewsnReleases
  • London Stock Exchange

    Elixirr International has acquired Kvadrant Consulting A/S

    ByNNR February 2, 2026February 2, 2026

    LONDON: Elixirr International plc on 30 January 2026 acquired the entire issued share capital of Kvadrant Consulting A/S, a Denmark-based consultancy specialising in commercial transformation, go-to-market excellence and transaction services, for a maximum consideration of DKK154.8 million (GBP£18.0 million). Highlights…

    Read More Elixirr International has acquired Kvadrant Consulting A/SContinue

  • London Stock Exchange

    AstraZeneca begins trading on the New York Stock Exchange

    ByNNR February 2, 2026February 2, 2026

    Ordinary shares now trade across the NYSE, LSE and STO under a harmonised global listing structure LONDON: AstraZeneca today begins trading its ordinary shares on the New York Stock Exchange (NYSE) for the first time, enabling more US investors to participate…

    Read More AstraZeneca begins trading on the New York Stock ExchangeContinue

  • Wire

    AstraZeneca deepens China bet with $15 billion investment, weight-loss drug deal ahead of NYSE listing

    ByNNR February 1, 2026February 1, 2026

    LONDON: AstraZeneca AZN.L is making a multi-billion dollar push into China, announcing a major investment and a new obesity drug partnership, as it prepares for a high-profile U.S. stock listing that underscores the pharmaceutical giant’s delicate balancing act between its…

    Read More AstraZeneca deepens China bet with $15 billion investment, weight-loss drug deal ahead of NYSE listingContinue

  • London Stock Exchange

    AstraZeneca agrees obesity and T2D deal with CSPC

    ByNNR January 30, 2026January 30, 2026

    LONDON: AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple next-generation therapies for obesity and type 2 diabetes across eight programmes. Under this agreement, the companies will initially…

    Read More AstraZeneca agrees obesity and T2D deal with CSPCContinue

  • Australian Exchange

    Australia’s AUI agrees to merge with Diversified United Investment in $2.5 billion deal

    ByNNR January 30, 2026January 30, 2026

    SYDNEY: Australian United Investment Company Ltd (AUI.AX) on Friday announced a proposed merger with Diversified United Investment Ltd (DUI.AX), creating a combined listed investment entity with an equity value of approximately A$2.53 billion ($1.7 billion). The all-share deal, structured as…

    Read More Australia’s AUI agrees to merge with Diversified United Investment in $2.5 billion dealContinue

  • London Stock Exchange

    British Land to acquire Life Science REIT in £150 million deal

    ByNNR January 28, 2026January 28, 2026

    LONDON – Property group British Land (BLND.L) has agreed to acquire real estate investment trust Life Science REIT (LABS.L) in a recommended cash and share deal valuing its smaller rival at approximately £150 million, the companies announced on Wednesday. The…

    Read More British Land to acquire Life Science REIT in £150 million dealContinue

  • London Stock Exchange

    Develop North PLC appoints Michelle Percy as its new Chief Executive Officer

    ByNNR January 26, 2026January 26, 2026

    LONDON: Develop North PLC, the North East England based investment company, is pleased to announce the appointment of Michelle Percy as its new Chief Executive Officer with immediate effect. Her appointment comes as the Company enters the next phase of…

    Read More Develop North PLC appoints Michelle Percy as its new Chief Executive OfficerContinue

  • Euronext

    bioMérieux buys Accellix to boost cell and gene therapy quality control

    ByNNR January 22, 2026January 22, 2026

    PARIS: French diagnostics group bioMérieux said on Thursday it has acquired U.S.-based Accellix, a developer of rapid, automated flow cytometry platforms, in a deal worth around €35 million. The acquisition strengthens bioMérieux’s pharmaceutical quality control business and expands its portfolio…

    Read More bioMérieux buys Accellix to boost cell and gene therapy quality controlContinue

  • London Stock Exchange

    Future plc acquires SheerLuxe and BLUSH Talent for up to £80 million

    ByAli Mirza January 22, 2026January 22, 2026

    LONDON: Future plc announced the acquisitions of 100% of SheerLuxe Ltd and BLUSH Talent MGMT Ltd, a UK-based digital publishing group that combines the authority of a trusted media brand with the authenticity and engagement of the creator economy. The…

    Read More Future plc acquires SheerLuxe and BLUSH Talent for up to £80 millionContinue

  • London Stock Exchange

    OEP Capital-backed bidco to acquire UK wholesaler Kitwave in £251 million deal

    ByBernice Miles January 22, 2026January 22, 2026

    LONDON: Kitwave Group plc, a leading UK delivered wholesale business, announced on Wednesday a recommended cash acquisition by Kite UK Bidco Limited, a newly-formed entity indirectly owned by funds managed by private equity firm OEP Capital Advisers, L.P. Under the…

    Read More OEP Capital-backed bidco to acquire UK wholesaler Kitwave in £251 million dealContinue

  • London Stock Exchange

    Drax Group agrees to acquire Flexitricity Limited for £36 million

    ByNNR January 21, 2026January 21, 2026

    LONDON – Drax Group has signed an agreement to acquire Flexitricity Limited, a UK-based optimiser of flexible energy assets, from Quinbrook. The transaction values Flexitricity at £36 million, which is subject to customary closing adjustments. Completion is expected in Q1…

    Read More Drax Group agrees to acquire Flexitricity Limited for £36 millionContinue

  • London Stock Exchange

    City of London Investment Group appoints Cooper Abbott as Chief Executive Officer

    ByAli Mirza January 21, 2026January 21, 2026

    LONDON: City of London Investment Group (LSE: CLIG), a leading specialist asset management group offering a range of institutional and retail products announced the appointment of Cooper Abbott as Chief Executive Officer and Executive Director with immediate effect. This appointment…

    Read More City of London Investment Group appoints Cooper Abbott as Chief Executive OfficerContinue

Page navigation

Previous PagePrevious 1 … 67 68 69 70 71 … 1,529 Next PageNext
  • Home
  • Listed Companies
  • Contact Us
  • London Stock Exchange
  • Singapore Exchange
  • Canadian Exchange
  • Australian Exchange
  • Oslo Bourse
  • PSX
  • Ratings
  • Euronext
  • MENA
  • Nasdaq Nordic
  • Wire
  • Business & Finance
  • Gadget Reviews
  • About NewsnReleases
Go to mobile version
  • Home
  • Euronext
  • Australian Exchange
  • London Stock Exchange
  • Wire
  • Business & Finance
  • Contact Us
Search